Long COVID Brain Fog Trial: Telehealth Goal Rehab Results

A new randomized trial tested a remote, individualized “goal-focused” cognitive rehabilitation program for adults with long COVID–related cognitive impairment—the symptom cluster many people describe as “brain fog.”

The headline result: people in the program reported better functional goal attainment after treatment, and that advantage was still present at 6 months.

The important nuance: the trial did not show broad, across-the-board improvements on every cognitive or symptom measure, and it did not find significant group differences for fatigue or post-exertional malaise (PEM). So this may help some everyday goals—but it’s not a “fix everything” intervention.

What the CICERO trial tested

The study was called CICERO (Cognitive Impairment in Long COVID: Phenotyping and Rehabilitation). It enrolled 78 adults ages 30 to 60 with objective cognitive impairment in at least two cognitive domains. Participants were randomized to:

Cognitive rehabilitation (CR): 10 weekly, 1-hour telehealth sessions with a trained researcher. The sessions targeted three individually selected, personally meaningful functional goals (often work- or daily-life related).
Treatment as usual (TAU): a variable comparison condition; many participants had access to specialist memory-clinic services.

The primary outcome was participant-reported goal attainment at 3 months (measured by the Bangor Goal-Setting Interview) and assessed again at 6 months.

What improved (and how long it lasted)

Functional goal attainment improved more with CR than with TAU.

At 3 months: adjusted mean difference 2.88 (95% CI, 2.03 to 3.73).
At 6 months: adjusted mean difference 1.72 (95% CI, 0.86 to 2.57).

The trial also reported that a higher proportion of people in the CR group met an exploratory “responder” threshold (for example, improving goal attainment by 2 or more points) at 3 months, with the group difference still present at 6 months.

What didn’t clearly improve

This is the part to read carefully if you’re hoping for “brain fog” to get better in every way.

No broad, across-the-board cognitive gains: the CR group showed advantages on some cognitive outcomes (for example, certain executive-function and processing-speed measures), but not a consistent pattern across every cognitive test.
No significant symptom changes (including fatigue and PEM): at 3 or 6 months, the trial did not find significant group differences for fatigue or post-exertional malaise (PEM) (as well as several other symptom outcomes, including anxiety, depression, and sleep disturbance).

How to interpret this for U.S. care (CDC context)

CDC’s long COVID clinical guidance emphasizes patient-centered approaches: clinicians should set achievable goals through shared decision-making and focus treatment on the most burdensome symptoms and conditions a person reports. CDC also describes PEM as worsening of symptoms after even minor physical or mental exertion, with symptoms typically worsening 12 to 48 hours after activity and lasting for days or even weeks.

Within that framework, the CICERO results are easiest to map to real life as:

Goal-focused rehab may help function: because the main benefit was improved goal attainment, it may translate into better performance on specific tasks people care about (work output, study routines, or daily activities).
It may not change core symptom patterns: fatigue and PEM weren’t significantly improved in this study, so readers should think of cognitive rehab as one potential component, not a substitute for symptom-specific management.
Rehab should be tailored to symptom triggers: if exertion worsens your symptoms, it’s reasonable to ask how the plan accounts for PEM risk and energy limitations.

Practical next steps: questions to ask

If you’re considering goal-focused cognitive rehab for long COVID brain fog, you can ask your clinician or rehab team:

What specific functional goals are we targeting—and how will we measure progress?
What’s the plan if symptoms flare? (For example, how will the approach be adjusted if you experience PEM or worsening fatigue.)
Is the approach individualized? CICERO used person-selected goals, not generic “brain games.”
What outcomes should I realistically expect? The best-supported outcome here is goal attainment, not universal cognitive or fatigue improvement.
How many sessions and what structure are typical?

How strong is the evidence?

This was a randomized clinical trial, which strengthens confidence in the direction of the benefit. But readers should keep limitations in mind:

Small sample size: 78 participants total.
Single-blind design: participants and care teams may not have been fully blinded to group assignment.
No active “time and attention” control: TAU was variable rather than an intervention matched for therapist contact and structure.
Implementation context: the study was conducted at sites in England, so access and delivery could differ in the U.S.

If you want to see details like eligibility criteria, the precise goal-attainment measures, and the full intervention outline, check the trial registration and report.

Where to check the trial details

ClinicalTrials.gov: CICERO study record (NCT05731570)
JAMA Network Open: the full randomized trial report

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.